CSIMarket
 
Windtree Therapeutics Inc  (WINT)
Other Ticker:  
 

Windtree Therapeutics Inc

Business Description


Windtree Therapeutics Inc. is a biotechnology company based in the United States that focuses on the development of novel therapies for respiratory diseases. The company was founded in 1997 and is headquartered in Warrington, Pennsylvania.

Windtree specializes in the research and development of technologies that aim to improve the delivery of medications into the lungs. They are known for their proprietary technology platform called the Aerosolized Intratracheal Pulmonary Administration (Aerogen) system. This system enables the delivery of small molecules, biologics, and cell therapies directly to the lungs, targeting respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS).

One of the main products in Windtree*s pipeline is KL4 surfactant, which is a synthetic lung surfactant used to treat respiratory distress syndrome in premature infants. Lung surfactants are essential for maintaining the normal function of the lungs and preventing respiratory distress. Windtree*s KL4 surfactant aims to provide a safe and effective alternative to animal-derived surfactants currently used in neonatal care.

Moreover, Windtree is also developing AEROSURF?, a combination therapy consisting of the KL4 surfactant and a proprietary aerosol delivery system. AEROSURF? aims to improve the administration of surfactant therapy to premature infants with respiratory distress syndrome, potentially reducing the need for invasive procedures such as intubation. This could have significant implications for the treatment of respiratory distress syndrome in the neonatal intensive care unit.

Apart from their focus on neonatal respiratory care, Windtree is also actively involved in the research and development of therapies for other respiratory conditions. They have ongoing clinical trials for the treatment of asthma, chronic lung disease associated with premature birth, and acute lung injury.

Windtree Therapeutics Inc. is committed to advancing respiratory healthcare through innovative technologies and therapies. They collaborate with leading experts in the field and continue to invest in research and development to address the unmet medical needs in respiratory diseases.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com